Loss of the OX40 Target in Lymphoma Patients after Combining an Anti-OX40 Agonist Antibody with in Situ VaccinationDebra K. Czerwinski,Tanaya Shree,Sarah Haebe, Shuyu Shi,Steven R. Long,Brock Martin,Ronald LevyBLOOD(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要